INTENSIVE IMMUNOCHEMOTHERAPY (R-Choep) VS HIGH-DOSE IMMUNOCHEMOTHERAPY (R-MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B-Cell LYMPHOMA: A 10-Year LONG-TERM FOLLOW-UP

Hematological Oncology - United Kingdom
doi 10.1002/hon.104_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long-Term Follow-Up of Patients With Non-Hodgkin Primary Diffuse Large B-Cell Lymphoma of the Stomach: Better Outcome After Immunochemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Reversible Hypopituitarism Associated With Intravascular Large B-Cell Lymphoma: Case Report of Successful Immunochemotherapy

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Long-Term Follow-Up After Localized Radiotherapy in Patients With Transformed B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Presentations, Treatment Complications and Outcomes in HCV-infected B-Cell Lymphoma Patients Treated With Immunochemotherapy: A Single Institute Retrospective Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy